Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VTRS
VTRS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VTRS News
Viatris Receives Overweight Rating and Price Target
3d ago
Yahoo Finance
Mark Cuban to Join Trump for Generic Drug Announcement
May 18 2026
seekingalpha
Viatris' NDA for Fast-Acting Meloxicam Accepted by FDA
May 18 2026
Newsfilter
HHS Considers Restrictions on Antidepressant Use Amid Mental Health Crisis
May 08 2026
seekingalpha
Viatris to Present at Bank of America Healthcare Conference
May 07 2026
PRnewswire
Viatris Reports Strong Q1 2026 Earnings with $3.5 Billion Revenue
May 07 2026
seekingalpha
Viatris Reaffirms Full-Year Outlook, Shares Surge
May 07 2026
seekingalpha
Viatris Executive Anticipates Mid to High Single-Digit Revenue Growth in Greater China by 2026 - Conference Call
May 07 2026
moomoo
Viatris Q1 Earnings Exceed Expectations
May 07 2026
seekingalpha
Viatris Set to Report Q1 Earnings Amid Pricing Pressures
May 06 2026
seekingalpha
Viatris Declares $0.12 Quarterly Dividend, Maintaining 3.16% Yield
May 05 2026
seekingalpha
Edwards Lifesciences Appoints New CFO
May 05 2026
NASDAQ.COM
Viatris CFO Theodora Mistras to Depart for New Opportunity
May 05 2026
NASDAQ.COM
Edwards Lifesciences Appoints New Executive
May 04 2026
Yahoo Finance
Viatris CFO Theodora Mistras to Depart for New Opportunity
May 04 2026
seekingalpha
Viatris CFO Departure; Paul Campbell Named Interim CFO
May 04 2026
PRnewswire
Show More News